Last update 12 Jul 2024

[11C]ER-176

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
11C-ER176
Target
Mechanism
TSPO inhibitors(Translocator protein inhibitors), PET imaging(Positron-emission tomography enhancers)
Originator Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

Structure

Molecular FormulaC20H20ClN3O
InChIKeyASFLYNMYGAYKON-XFBLKYPGSA-N
CAS Registry1623028-18-1

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic GastroparesisPhase 3
US
10 May 2021
Multiple SclerosisPhase 2
US
10 Apr 2023
Alzheimer DiseasePhase 2
US
11 May 2021
DementiaPhase 1
US
03 Jul 2019
DementiaPhase 1
US
03 Jul 2019
MyositisPhase 1
US
14 Jun 2019
MyositisPhase 1
US
14 Jun 2019
Rheumatoid ArthritisPhase 1
US
14 Jun 2019
Rheumatoid ArthritisPhase 1
US
14 Jun 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
13
Positron Emission Tomography (PET) Scan+11C-ER176+11C-PIB
(Healthy Volunteers)
owwjhznupm(etqcpvzwrl) = cxdtiwvrpy zaazbmqqgc (mvbghpmhrn, pbvzmchpyu - xfkmcpumdj)
-
01 May 2024
Positron Emission Tomography (PET) Scan+11C-ER176+11C-PIB
(Subjects With Frontotemporal Dementia (FTD))
owwjhznupm(etqcpvzwrl) = yitzgenemc zaazbmqqgc (mvbghpmhrn, acghrmvedb - mcmqjolmej)
Phase 1/2
9
(Cognitive Impairment)
kaxitnwsij(ueimjtcwol) = mhovyqzfya fldphfxmix (ysdthssjya, fvfhietfwm - yywjynmxut)
-
13 Sep 2023
(No Cognitive Impairment)
kaxitnwsij(ueimjtcwol) = dugupncimr fldphfxmix (ysdthssjya, pfivyaemuz - iywrmjxedj)
Phase 2/3
12
Core biopsy of gastric muscle+PET/CT Scan
(Diabetic Gastroparesis Subjects)
hjuztjkmxf(yawkhlqauo) = vaydqoafbt ehlbixxcgb (vnyebngpxz, uyirteojcg - qriwzowvpt)
-
18 Apr 2023
(Diabetic Without Gastroparesis Subjects)
hjuztjkmxf(yawkhlqauo) = iuslqannjv ehlbixxcgb (vnyebngpxz, jpuhkoqbnm - suvzdvqidr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free